Xerostomia in long-term survivors of aggressive non-hodgkin's lymphoma f waldeyer's ring: A potential role for parotid-sparing techniques?

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 32, Issue 2, 2009, Pages 145-149

  Chang, Daniel T ^a   Amdur, Robert J ^a   Pacholke, Heather ^b   Mendenhall, Nancy P ^a   Morris, Christopher G ^a   Byer, Gracie A ^a   Olivier, Kenneth R ^a,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Southeast Radiation Oncology   (United States)

^c NONE   (United States)

Author keywords

Non Hodgkin's lymphoma; Quality of life; Waldeyer's ring; Xerostomia

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVOR; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LARYNX; MALE; NONHODGKIN LYMPHOMA; PAROTID GLAND; QUESTIONNAIRE; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; WALDEYER RING; WALDEYER RING NON HODGKIN LYMPHOMA; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; PAROTID GLAND; PROGNOSIS; QUESTIONNAIRES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; SURVIVORS; TREATMENT OUTCOME; XEROSTOMIA; YOUNG ADULT;

EID: 67749114691     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181841f42     Document Type: Article

References (27)

1. Rosenberg SA, Diamond HD, Jaslowitz B, et al. Lymphosarcoma: a review of 1269 cases. Medicine (Baltimore). 1961;40:31-84.
2. Hoppe RT, Burke JS, Glatstein E, et al. Non-Hodgkin's lymphoma: involvement of Waldeyer's ring. Cancer. 1978;42:1096-1104.
3. Saul SH, Kapadia SB. Primary lymphoma of Waldeyer's ring. Clinicopathologic study of 68 cases. Cancer. 1985;56:157-166.
4. Aviles A, Delgado S, Ruiz H, et al. Treatment of non-Hodgkin's lymphoma of Waldeyer's ring: radiotherapy versus chemotherapy versus combined therapy. Eur J Cancer B Oral Oncol. 1996;32B:19-23.
5. Uematsu M, Kondo M, Hiramatsu H, et al. Stage IA non-Hodgkin's lym-phoma of the Waldeyer's ring. Limited chemotherapy and radiation therapy versus radiation therapy alone. Acta Oncol. 1993;32:675-678.
6. Liang R, Ng RP, Todd D, et al. Management of stage I-II diffuse aggressive non-Hodgkin's lymphoma of the Waldeyer's ring: combined modality therapy versus radiotherapy alone. Hematol Oncol. 1987;5:223-230.
7. Hayabuchi N, Jingu K, Miyoshi M, et al. Radiotherapy and chemotherapy in stages I and II non-Hodgkin's lymphomas of Waldeyer's ring. Nippon Gan Chiryo Gakkai Shi. 1990;25:1428-1436.
8. Butler EB, Teh BS, Grant WH, III, et al. SMART (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys. 1999;45:21-32.
9. Eisbruch A, Ten Haken RK, Kim HM, et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577-587.
10. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109 -122.
11. Eisbruch A, Dawson LA, Kim HM, et al. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life. Acta Otorhinolaryngol Belg. 1999;53:271-275.
12. Eisbruch A, Rhodus N, Rosenthal D, et al. How should we measure and report radiotherapy-induced xerostomia? Semin Radiat Oncol. 2003;13:226 -234.
13. Eisbruch A, Kim HM, Terrell JE, et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:695-704.
14. Lin A, Kim HM, Terrell JE, et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys. 2003;57:61-70.
15. Pacholke HD, Amdur RJ, Morris CG, et al. Late xerostomia after intensitymodulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol. 2005;28:351-358.
16. Jabbari S, Kim HM, Feng M, et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys. 2005;63:725-731.
17. Roesink JM, Moerland MA, Battermann JJ, et al. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys. 2001;51:938-946.
18. Parliament MB, Scrimger RA, Anderson SG, et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:663-673.
19. Blanco AI, Chao KS, El Naqa I, et al. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:1055-1069.
20. Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 2000;18:3339-3345.
21. Braam PM, Roesink JM, Moerland MA, et al. Long-term parotid gland function after radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:659-664.
22. Jha N, Seikaly H, Harris J, et al. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol. 2003;66:283-289.
23. Murdoch-Kinch C, Kim H, Eisbruch A. Dose-Response Relationships for the Submandibular Salivary Glands (SMSG). Int J Radiat Oncol Biol Phys. 2007;69:S52-S53.
24. Manschreck TC, Leighton AH. Reducing disability in mood disorders and schizophrenia. Hosp Community Psychiatry. 1992;43:179-180.
25. Chang DW, Reece GP, Wang B, et al. Effect of smoking on complications in patients undergoing free TRAM flap breast reconstruction. Plast Reconstr Surg. 2000;105:2374-2380.
26. Spear SL, Ducic I, Cuoco F, et al. The effect of smoking on flap and donor-site complications in pedicled TRAM breast reconstruction. Plast Reconstr Surg. 2005;116:1873-1880.
27. Li Y, Taylor JM, Ten Haken RK, et al. The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2007;67:660-669.